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Lung cancer mortality patterns throughout Europe are very heterogeneous and largely reﬂect past smoking habits. In order to
clarify the changing patterns of lung cancer in Europe we have plotted the overall lung cancer trends among men and women
for 20 countries from 1950 up to1998. Furthermore, using a Bayesian age-period-cohort approach, we have calculated 5 year
projections of lung cancer rate up to 2003. Finally, we make some comments on probable future trends by analysing recent
trends in adults aged 555 years. Lung cancer mortality rates up to age 75 years portray a general trend of decreasing lung
cancer rates among men and increasing lung cancer rates among women. Exceptions to this decrease among men include
Hungary where not only are current mortality rates much higher than previously observed in any other country (at 76.7 out of
100000 in 1998) but they are projected to increase further in the short term. Rates among adults aged 555 years have
recently peaked, indicating that overall rates are likely to peak in the next decade. Among women, rapid increases have been
observed in Denmark, Netherlands, Hungary, Ireland and UK. Whereas Ireland and UK rates have started to decrease and are
projected to continue falling, rates in the other three countries are projected to increase further. Trends in women aged 555
years indicate that rates in Danish women will peak in the next decade, whereas lung cancer rates among Dutch women are
likely to continue increasing. Rates in Hungarian women are likely to increase and will surpass the current high rate observed
in Denmark.
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Lung cancer is the most common cause of cancer mortality among
men in Europe, and is becoming an increasingly important cause
of cancer mortality among women (Bray et al, 2002). Lung cancer
mortality patterns throughout Europe are very heterogeneous and
largely reﬂect past smoking habits (Kubik et al, 1995), although
changes in cigarette composition are also likely to be important.
In order to clarify the changing patterns of lung cancer in Europe
we have plotted the overall lung cancer trends among men and
women for 20 countries from 1950 up to the most recent collection
of data, usually 1996–1998, depending on each country. Further-
more, using a recently validated Bayesian age-period-cohort
approach, we have calculated 5 year projections of lung cancer rate
up to 2001–2003. Given the delay of several years in obtaining
cancer mortality data these short term projections serve as a
measure of current lung cancer mortality. Finally, as changes in
lung cancer rates tend to be observed ﬁrst among younger age
groups, we make some comments on likely future trends by analys-
ing recent trends in adults aged less than 55 years.
METHODS
Ofﬁcial lung cancer mortality ﬁgures for 20 European countries,
stratiﬁed for sex and 5 year age groups, were obtained from the
WHO mortality database for the years 1950–1998. Information
from other European countries over this time period was not avail-
able. Information from the former-Czechoslovakia was not
available after 1991, and lung cancer mortality for 1992–1998
was estimated using data from the Czech Republic. Due to the
unreliability of death certiﬁcation in the very old, age groups from
75 years and above were excluded. Age and sex speciﬁc estimates of
the population in each country were also obtained.
Short-term mortality projections were made using a generalised
Bayesian age-period-cohort model (Bashir and Esteve, 2001; Bray,
2002; Knorr-Held and Rainer, 2001). Age-period-cohort models
simultaneously estimate the increasing risk of mortality with age,
cohort effects (factors affecting a group of people born around
the same time) and period effects (which apply to all people at a
certain point in time). Cohort effects arise when different birth
cohorts have different levels of exposure to a particular risk factor
(e.g. cigarette smoking). Temporal changes which affect all
members of the population (e.g. air pollution, a change in cigarette
composition or a new treatment) are examples of period effects
which could affect cancer mortality rates. Identifying individual
cohort, period or age effects is impossible with making further
assumptions, although this identiﬁability problem is not of concern
when making projections.
Projections based on extrapolating classical estimates of age,
period and cohort effects require the analyst to make parametric
assumptions (Osmond, 1985) and are sensitive to variation in
the most recent cohort effects, which can be unstable due to small
numbers. The Bayesian approach presented here uses non-para-
metric smoothing to reduce variation, hence improving the
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belief about the smoothness of the age, period and cohort effects
(Berzuini and Clayton, 1994). This is achieved by specifying an
autoregressive prior model which smoothes effects on each time
scale, preventing parameter estimates from differing too much
from those in adjacent time bands. The expected value for each
effect is based on an extrapolation from its two immediate prede-
cessors. The autoregressive model extrapolates period and cohort
effects forward to make projections for rates in future periods,
(age effects are not extrapolated since the age groups of interest
in future periods do not change). Problems in identifying and
interpreting individual parameters, caused by the linear relation-
ship between age, period and cohort effects in these models, do
not affect projected rates.
Five year age-standardised ﬁtted and projected rates were esti-
mated from samples of 15000 drawn from the posterior
distribution, taking the median as an overall summary rate. 90%
credible intervals were calculated as the 5th and 95th percentiles
of the samples (a credible interval may be interpreted as a conﬁ-
dence interval calculated using Bayesian techniques). All age-
standardised mortality rates were calculated using the world stan-
dard truncated at age 75 years (Parkin et al, 1997). Further
information on methods and implementation are described else-
where (Bashir and Esteve, 2001; Bray, 2002; Knorr-Held and
Rainer, 2001).
This method has been compared with three alternative models
for both incidence and mortality data and a variety of different
cancer sites by comparing the performance of empirical projections
(Bashir and Esteve, 2001; Bray, 2002). Overall, the Bayesian projec-
tions outperformed all other methods considered. This method is
also robust and was found to work well in situations where other
approaches failed, such as when the numbers of observed cases are
very small.
RESULTS
Lung cancer mortality rates up to age 75 years portray a general
trend of decreasing lung cancer rates among men and increasing
lung cancer rates among women (Figure 1 and Table 1). Among
men, countries in which lung cancer rates peaked early, including
Finland, UK, Belgium and The Netherlands, reported peak mortal-
ity rates of approximately 60 out of 100000, although these have
since substantially declined, and short term projections conﬁrm
that these declines are likely to continue. Other countries in North-
ern and Western Europe have also peaked, although at much lower
levels, and some decline in incidence is now evident. In southern
Europe, rates among men have peaked in Italy at a moderate level
and are now decreasing, whereas rates are constant in Greece and
France, and gradually increasing in Spain. In Central Europe a very
heterogeneous picture is observed, with Romania and Bulgaria
having moderate rates similar to Southern Europe. Rates in Poland
and Czech Republic both peaked during the 1990s at very high
levels, although a decrease is now evident in both countries, espe-
cially in Czech Republic. Mortality rates in Hungary are however
surprising. Not only are current mortality rates (76.7 out of
100000, age-adjusted for age group 0–74, in 1998) much higher
than previously observed in any other country but they are
projected to increase further in the short term. The current male
lung cancer mortality rate in Hungary represents the highest
national lung cancer mortality rate ever observed.
Lung cancer mortality rates among women over the last 50 years
have increased in most countries (Figure 1 and Table 1). In North-
ern Europe, a very rapid increase in lung cancer mortality rates has
been observed in Denmark, which now has the highest female
national mortality rates in the world. Short term projections do
not indicate that this mortality rate is about to peak. In Western
Europe, high mortality rates observed in UK and Ireland have
peaked and are now decreasing. In contrast, female lung cancer
mortality in The Netherlands is rapidly increasing and is projected
to surpass UK and Ireland rates. In Central Europe, a dramatic
increase has been observed in Hungary and is projected to further
increase in the short term. Elsewhere in Central and Southern
Europe, lung cancer rates are still relatively low, although the
beginning of the lung cancer epidemic may be observed in several
countries including Poland, Czech Republic and France.
Age standardised rates up to age 54 years indicate that usually, a
sharp decline in the middle age may anticipate by about 10–15
years a decline in mortality rates overall. For example, male and
female rates up to age 55 years in the UK peaked around 1955
and 1975 respectively (Figure 2), whereas the rates up to age 75
years peaked around 1970 and 1990 respectively (Figure 1). Similar
trends may be seen in Finnish, Dutch, Polish and Italian men,
where overall decreases are evident, as well as among Irish women.
Such a relationship is expected, as lung cancer rates are strongly
related to previous cohort changes in smoking practices and will
ﬁrst become apparent when the cohort is in middle age. Even so,
this relationship is not evident in all cases and, for example, among
Belgian and Czech men, declines in middle age and overall tended
to occur almost concurrently, indicating that period effects related
to smoking or other factors also play a role.
Those countries which have seen a sharply increasing lung
cancer mortality rate which are projected to increase at least in
the short term and which are therefore of major concern include
Hungarian men, and Danish, Dutch and Hungarian women. Rates
in Hungarian men aged up to 55 years are likely to have peaked
and a slight decline is projected in the short term, indicating that
overall rates are likely to peak soon, although at a very high level
(Figure 2 and Table 1). Similarly, among Danish women rates have
peaked in the age group up to 55 years and are currently decreas-
ing, indicating that overall lung cancer rates should soon peak close
to their current high level, probably at around 30 out of 100000,
and start to decrease. In Hungary, female lung cancer mortality
rates have shown a constant increase up to 1998, although 5 year
projections indicate that they may have peaked at their current
high level (7.6 out of 100000). The 90% credible interval of
(5.61, 10.14) is wide and it is not possible to make ﬁrm predictions
regarding Hungarian female lung cancer rates in the medium term.
However, rates among Hungarian women aged less than 55 years
are substantially higher than the maximum rate observed among
Danish women in this age group, indicating the mortality rate
among all Hungarian women is likely to exceed the current high
rates observed among Danish women. Finally, in The Netherlands
a constant increase has been observed in younger women indicat-
ing that the overall increase is likely to continue.
DISCUSSION
In summary, age standardised lung cancer mortality rates among
men have peaked or are decreasing in all European countries
included in this analysis except for Hungary, and possibly Spain.
Among adults aged less than 55 years, mortality rates in both Spain
and Hungary appear to be in the process of peaking, indicating
that a peak in the overall rate is likely to occur in the next 10 years.
While the peak mortality rate in Spain will occur at a relatively
modest level, the peak in Hungarian rates, when it occurs, is are
likely to represent the highest national lung cancer mortality rate
observed for any country. Among women, although rates are
decreasing in UK and Ireland, it is likely that substantial increases
will be observed for most other countries.
Trends in lung cancer mortality rates are known to occur largely
as a result of cohort effects in speciﬁc populations, which is almost
entirely related to practices in cigarette smoking. In theory, it may
be possible to improve the predictive accuracy of these models by
incorporating past information on cigarette consumption. Informa-
tion is available for the proportion of adult smokers among men
and women in each country from the WHO ‘Health For All’ data-
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British Journal of Cancer (2002) 87(1), 43–48 ã 2002 Cancer Research UKbase and is included in Table 2 for all countries in the current
analysis along with Slovakia and Russia. However, accurate age
speciﬁc information on smoking prevalence would be required if
this information were to be incorporated into the prediction model
and this information is not available. The smoking prevalence data
do however indicate that overall smoking has decreased among
men in nearly all countries in Northern, Western and Southern
Europe. In Central and Eastern Europe, a substantial decrease
has been observed in Czech Republic which is balanced by an iden-
tical increase in neighboring Slovakia. Whether this is due to
methodological differences in the surveys or represents a real
phenomenon is not clear. A large increase in smoking prevalence
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Figure 1 Age standardised rates (0–74 years). The y axis represents standardised rates per 100000 and the x axis represents calendar year. Points mark
the end of the observed data and the beginning of the 5-year projections.
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Table 1 Lung cancer mortality rates and 5 year projections (90% credible intervals) for 20 European countries
Ages 0–54 Ages 0–74
Men Women Men Women
Country Year
Mortality
rate
5 year projection
(90% credible
interval)
Mortality
rate
5 year projection
(90% credible
interval)
Mortality
rate
5 year projection
(90% credible
interval)
Mortality
rate
5 year projection
(90% credible
interval)
Northern Europe
Denmark 1996 6.08 5.98 (4.78, 7.51) 5.31 4.99 (2.84, 6.55) 34.8 32.9 (26.8, 40.4) 25.2 27.0 (21.0, 34.6)
Finland 1996 4.07 3.71 (2.89, 4.76) 1.28 1.19 (0.89, 1.59) 30.0 23.8 (18.9, 29.7) 10.6 10.3 (8.0, 13.4)
Norway 1995 4.13 3.56 (2.72, 4.66) 3.03 3.30 (2.40, 4.54) 26.4 25.7 (20.3, 32.5) 11.6 14.3 (10.7, 19.0)
Sweden 1996 2.77 2.14 (1.68, 2.71) 3.17 3.23 (2.48, 4.24) 17.2 15.2 (12.1, 18.8) 11.2 13.3 (10.5, 17.2)
Western Europe
Austria 1998 7.26 5.48 (4.24, 7.07) 3.10 3.08 (2.34, 4.10) 32.4 29.3 (23.3, 37.2) 9.2 10.7 (8.2, 13.7)
Belgium 1994 10.26 8.91 (7.27, 10.92) 2.68 3.00 (2.29, 3.88) 54.5 50.7 (41.9, 61.8) 8.3 10.0 (7.8, 12.8)
Germany 1997 6.97 5.63 (4.81, 6.61) 2.81 2.77 (2.22, 3.48) 36.0 32.9 (28.1, 38.4) 8.2 9.8 (7.9, 12.2)
Ireland 1996 4.51 3.61 (2.57, 5.05) 2.46 2.10 (1.47, 2.98) 31.4 26.7 (19.5, 35.8) 13.6 12.5 (9.2, 17.0)
Netherlands 1997 6.09 5.00 (4.15, 6.00) 4.23 4.68 (3.65, 5.94) 43.2 36.7 (30.8, 43.6) 13.4 16.3 (12.9, 20.4)
Switzerland 1994 6.17 5.60 (4.53, 6.89) 2.56 3.38 (2.44, 4.76) 33.6 29.5 (24.2, 35.7) 8.3 11.3 (8.6, 15.2)
UK 1996 4.91 3.64 (3.14, 4.21) 3.02 2.58 (2.18, 3.04) 34.4 27.4 (23.8, 31.6) 17.0 15.6 (13.3, 18.3)
Central Europe
Bulgaria 1998 12.82 11.14 (8.62, 14.08) 3.24 3.19 (2.30, 4.30) 36.9 32.3 (25.1, 40.5) 7.6 7.3 (5.3, 9.6)
Czech Republic 1998 11.16 7.53 (6.16, 9.14) 2.73 2.51 (1.88, 3.29) 53.3 42.8 (35.3, 51.4) 9.9 10.6 (8.1, 13.6)
Hungary 1998 23.53 21.80 (17.89, 26.74) 7.60 7.60 (5.61, 10.14) 76.7 78.8 (65.0, 95.9) 18.0 22.4 (16.8, 29.3)
Poland 1996 13.26 11.12 (9.22, 13.38) 3.35 3.42 (2.72, 4.28) 63.2 59.1 (49.2, 70.6) 9.9 11.7 (9.4, 14.5)
Romania 1998 14.61 14.20 (11.23, 17.81) 2.36 2.54 (1.96, 3.30) 43.5 42.4 (33.8, 52.9) 6.8 7.4 (5.7, 9.4)
Southern Europe
France 1996 10.92 10.46 (8.74, 12.50) 1.90 2.35 (1.87, 2.97) 3.95 40.1 (33.7, 47.8) 5.4 7.1 (5.7, 9.0)
Greece 1997 10.36 10.11 (7.96, 12.71) 1.73 1.64 (1.22, 2.19) 40.8 40.2 (31.9, 50.2) 5.6 5.6 (4.2, 7.3)
Italy 1995 7.76 5.97 (4.96, 7.15) 1.74 1.71 (1.41, 2.09) 43.3 36.2 (30.2, 43.0) 6.3 6.7 (5.5, 8.1)
Spain 1995 10.41 10.87 (8.68, 13.75) 1.21 1.37 (1.02, 1.85) 40.5 43.2 (34.6, 54.3) 3.1 3.7 (2.8, 4.9)
Age standardised rates by 5 year age group. Predictions made over 5 year period starting from year of last available data (column 2).
Table 2 Per cent regular daily smokers aged 15+ years in 1990 and 2000 for 22 European countries (WHO Health For All database)
Men Women
Country
Smokers in 1980
(%)
Smokers in 1990
(%)
Smokers in 2000
(%)
Smokers in 1980
(%)
Smokers in 1990
(%)
Smokers in 2000
(%)
Northern Europe
Denmark 39 32 35 29
Finland 33 32 27 17 20 20
Norway 42 36 31 31 33 32
Sweden 36 26 19 29 26 19
Western Europe
Austria 36 30 20 19
Belgium 53 38 31 28 26 26
Germany 34 36 20 22
Ireland 39 31 32 32 29 31
Netherlands 52 42 37 34 31 30
Switzerland 37 38 24 27
UK 42 31 28 37 29 26
Central Europe
Bulgaria 49 49 17 24
Czech Republic 43 36 31 22
Hungary 53 30
Poland 51 29
Romania 44 10
Russia
Slovakia
Southern Europe
France 46 48 40 17 33 32
Greece 60 47 32 29
Italy 36 33 16 17
Spain 44 42 21 25
Figures for 2000 represent the closest available estimate taken from the period 1996–2000. Figures for 1990 represent the closest available ﬁgure in the period
1989–1994. Figures for 1980 represent the closest available ﬁgure in the period 1980–1982.
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British Journal of Cancer (2002) 87(1), 43–48 ã 2002 Cancer Research UKhas also been observed among Russian men, whereas survey infor-
mation at two different time points was not available for Hungary,
Poland and Romania. Among women a decrease in tobacco
consumption has been observed in several countries including
Denmark, Sweden, Czech Republic and UK, whereas constant or
increasing tobacco consumption patterns have been observed for
other countries.
These trends illustrate the large potential for tobacco control on
lung cancer mortality. The evidence from the two countries where
the lung cancer epidemic ﬁrst peaked (UK and Finland) is that if
anti-smoking policies are adopted which result in cessation of
smoking among a large proportion of current smokers then these
trends can be reversed. Five-year projections of lung cancer mortal-
ity among men in UK and Finland indicate that current rates in
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Figure 2 Age standardised rates (0–54 years). The y axis represents standardised rates per 100000 and the x axis represents calendar year. Points mark
the end of the observed data and the beginning of the 5-year projections.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(1), 43–48these two countries are likely to be among the lowest in Europe,
with only Norway and Ireland having comparable rates and
Sweden having substantially lower rates. However, such a decline
in lung cancer rates is not inevitable and is unlikely to occur in
the absence of strong public health campaigns, which encourage
current smokers to quit smoking. Although there are potential
gains to be made in all countries in terms of reducing tobacco
consumption, a clear priority for such work is in Central Europe,
which has recently seen massive investment by foreign tobacco
companies.
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